{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:28:03Z","timestamp":1792787283218,"version":"4.5.0"},"reference-count":37,"publisher":"BMJ","issue":"2","license":[{"start":{"date-parts":[[2023,11,10]],"date-time":"2023-11-10T00:00:00Z","timestamp":1699574400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Boston Scientific","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Frontline Gastroenterol"],"accepted":{"date-parts":[[2023,10,24]]},"published-print":{"date-parts":[[2024,3]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>The Inflammatory Bowel Disease Disability Index (IBD-DI) was developed according to WHO standards and has been validated in population-based cohorts. However, there are limited data on its relationship to various psychosocial and economic variables or its relevance to hospital clinical practice. The study aims were to determine the validity and reliability of the IBD-DI in an English-speaking hospital out-patient population and to evaluate its association with short and long-term disease activity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design\/Methods<\/jats:title>\n                    <jats:p>329 subjects were enrolled in a cross-sectional and longitudinal study assessing the IBD-DI and a range of quality of life, work impairment, depression, anxiety, body image, interpersonal, self-esteem, disease activity, symptom scoring scales in addition to long-term outcome.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The IBD-DI had adequate structure, was internally consistent and demonstrated convergent and predictive validity and was reliable in test\u2013retest study. Disability was related to female sex (p=0.002), antidepressant use (p&lt;0.001), steroid use (p&lt;0.001) and disease activity (p&lt;0.001). Higher IBD-DI scores were associated with long-term disease activity and need for treatment escalation in univariate (p&lt;0.001) and multivariate (p=0.002) analyses.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The IBD-DI is a valid and reliable measure of disability in English-speaking hospital populations and predicts long-term requirement for treatment escalation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/flgastro-2023-102428","type":"journal-article","created":{"date-parts":[[2023,11,10]],"date-time":"2023-11-10T13:20:34Z","timestamp":1699622434000},"page":"130-136","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":5,"title":["Inflammatory Bowel Disease Disability Index is a valid and reliable measure of disability in an English-speaking hospital practice and predicts long-term requirement for treatment escalation"],"prefix":"10.1136","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4472-9269","authenticated-orcid":false,"given":"Darragh","family":"Storan","sequence":"first","affiliation":[{"name":"Department of Gastroenterology, Saint Vincent's University Hospital, Dublin, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edel","family":"McDermott","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Saint Vincent's University Hospital, Dublin, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenny","family":"Moloney","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, St Luke\u2019s Hospital, Kilkenny, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Keenan","sequence":"additional","affiliation":[{"name":"School of Psychology, University College Dublin, Dublin, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roisin","family":"Stack","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Saint Vincent's University Hospital, Dublin, Ireland"},{"name":"Department of Gastroenterology, St Luke\u2019s Hospital, Kilkenny, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliette","family":"Sheridan","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Saint Vincent's University Hospital, Dublin, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glen","family":"Doherty","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Saint Vincent's University Hospital, Dublin, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Garret","family":"Cullen","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Saint Vincent's University Hospital, Dublin, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise","family":"McHugh","sequence":"additional","affiliation":[{"name":"School of Psychology, University College Dublin, Dublin, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7087-6177","authenticated-orcid":false,"given":"Hugh E","family":"Mulcahy","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Saint Vincent's University Hospital, Dublin, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2023,11,10]]},"reference":[{"key":"2025090708053496000_15.2.130.1","unstructured":"World Health Organization . International classification of impairments, disabilities and handicaps of the World Health Organisation. 1976."},{"key":"2025090708053496000_15.2.130.2","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1177\/1756283X17732720","article-title":"Preventing disability in inflammatory bowel disease","volume":"10","author":"Allen","year":"2017","journal-title":"Therap Adv Gastroenterol"},{"key":"2025090708053496000_15.2.130.3","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1984.tb14805.x"},{"key":"2025090708053496000_15.2.130.4","first-page":"540","article-title":"Comparison of functional disability scales and their relevance to radiological progression in patients with rheumatoid arthritis in remission","volume":"24","author":"Sahin","year":"2006","journal-title":"Clin Exp Rheumatol"},{"key":"2025090708053496000_15.2.130.5","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2020.12.031"},{"key":"2025090708053496000_15.2.130.6","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(89)90905-0"},{"key":"2025090708053496000_15.2.130.7","first-page":"1571","article-title":"The short inflammatory bowel disease questionnaire: a quality of life instrument for community physicians managing inflammatory bowel disease","volume":"91","author":"Irvine","year":"1996","journal-title":"Am J Gastroenterol"},{"key":"2025090708053496000_15.2.130.8","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2014.02.016"},{"key":"2025090708053496000_15.2.130.9","first-page":"300","article-title":"Measuring disability in IBD: the IBD disability index","volume":"9","author":"Colombel","year":"2013","journal-title":"Gastroenterol Hepatol (N Y)"},{"key":"2025090708053496000_15.2.130.10","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1053\/j.gastro.2022.06.068","article-title":"CORE-IBD: a multidisciplinary International consensus initiative to develop a core outcome set for randomized controlled trials in inflammatory bowel disease","volume":"163","author":"Ma","year":"2022","journal-title":"Gastroenterology"},{"key":"2025090708053496000_15.2.130.11","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2011-300049"},{"key":"2025090708053496000_15.2.130.12","unstructured":"U.S Department of Health and Human Services Food and Drug Administration (FDA) . Guidance for Industry: patientreported outcome measures: use in medical product development to support labeling claims. Maryland, US: FDA, 2009."},{"key":"2025090708053496000_15.2.130.13","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2015-310151"},{"key":"2025090708053496000_15.2.130.14","doi-asserted-by":"publisher","DOI":"10.1093\/ibd\/izx063"},{"key":"2025090708053496000_15.2.130.15","doi-asserted-by":"publisher","DOI":"10.1097\/MEG.0000000000000701"},{"key":"2025090708053496000_15.2.130.16","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/jgh.14496","article-title":"Validation of the inflammatory bowel disease disability index for self-report and development of an item-reduced version","volume":"34","author":"Paulides","year":"2019","journal-title":"J Gastroenterol Hepatol"},{"key":"2025090708053496000_15.2.130.17","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/1751-2980.12836","article-title":"Development of a validated Chinese version of the inflammatory bowel disease disability index","volume":"21","author":"Zhang","year":"2020","journal-title":"J Dig Dis"},{"key":"2025090708053496000_15.2.130.18","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph16040635","article-title":"Cultural adaptation and validation of the inflammatory bowel disease disability index in a Spanish population and its association with sociodemographic and clinical factors","volume":"16","author":"L\u00f3pez-Cort\u00e9s","year":"2019","journal-title":"Int J Environ Res Public Health"},{"key":"2025090708053496000_15.2.130.19","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.20255"},{"key":"2025090708053496000_15.2.130.20","doi-asserted-by":"publisher","DOI":"10.2165\/00019053-199304050-00006"},{"key":"2025090708053496000_15.2.130.21","doi-asserted-by":"publisher","DOI":"10.1002\/1097-4679(198411)40:6&lt;1365::AID-JCLP2270400615&gt;3.0.CO;2-D"},{"key":"2025090708053496000_15.2.130.22","doi-asserted-by":"publisher","DOI":"10.1177\/135245859900500409"},{"key":"2025090708053496000_15.2.130.23","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2008.10.018"},{"key":"2025090708053496000_15.2.130.24","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2018.01.027"},{"key":"2025090708053496000_15.2.130.25","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2019-318484"},{"key":"2025090708053496000_15.2.130.26","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2019-318343"},{"key":"2025090708053496000_15.2.130.27","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2015.12.045"},{"key":"2025090708053496000_15.2.130.28","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1097\/MPG.0000000000000885","article-title":"Baseline characteristics and disease phenotype in inflammatory bowel disease","volume":"62","author":"M\u00fcller","year":"2016","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"2025090708053496000_15.2.130.29","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1080\/00365521.2016.1250942","article-title":"Long-term outcome of inflammatory bowel disease patients with deep remission after discontinuation of TNF\u03b1-blocking agents","volume":"52","author":"Molander","year":"2017","journal-title":"Scand J Gastroenterol"},{"key":"2025090708053496000_15.2.130.30","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2007.134817"},{"key":"2025090708053496000_15.2.130.31","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2009.02.069"},{"key":"2025090708053496000_15.2.130.32","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1720696115"},{"key":"2025090708053496000_15.2.130.33","doi-asserted-by":"publisher","DOI":"10.1016\/j.crohns.2008.01.002"},{"key":"2025090708053496000_15.2.130.34","doi-asserted-by":"publisher","DOI":"10.1097\/00004836-200101000-00015"},{"key":"2025090708053496000_15.2.130.35","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1053\/j.gastro.2018.11.030","article-title":"Acceptance and commitment therapy reduces psychological stress in patients with inflammatory bowel diseases","volume":"156","author":"Wynne","year":"2019","journal-title":"Gastroenterology"},{"key":"2025090708053496000_15.2.130.36","doi-asserted-by":"publisher","DOI":"10.1097\/MEG.0b013e32834d09f1"},{"key":"2025090708053496000_15.2.130.37","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.1016\/j.cgh.2020.08.053","article-title":"An international multicenter comparison of IBD-related disability and validation of the IBDDI","volume":"19","author":"Shafer","year":"2021","journal-title":"Clin Gastroenterol Hepatol"}],"container-title":["Frontline Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/flgastro-2023-102428","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T15:05:44Z","timestamp":1757257544000},"score":1,"resource":{"primary":{"URL":"https:\/\/fg.bmj.com\/lookup\/doi\/10.1136\/flgastro-2023-102428"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,10]]},"references-count":37,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,2,14]]},"published-print":{"date-parts":[[2024,3]]}},"alternative-id":["10.1136\/flgastro-2023-102428"],"URL":"https:\/\/doi.org\/10.1136\/flgastro-2023-102428","relation":{},"ISSN":["2041-4137","2041-4145"],"issn-type":[{"value":"2041-4137","type":"print"},{"value":"2041-4145","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,10]]}}}